Archive Newsletter

  1. 01.13.26 -- What 2025 FDA Warning Letters Tell Us About GMP Compliance 1/13/2026
    01/13/26 Clinical Supply Leader Newsletter
  2. 01.06.26 -- The Trends Shaping Clinical Trial Supply In 2025 And Beyond 1/6/2026
    01/06/26 Clinical Supply Leader Newsletter
  3. Best of 2025: Top 10 Insights In Clinical Supply Chain & Logistics 12/23/2025
  4. 12.23.25 -- Clinical Supply's Role In Driving Success In Decentralized Trials 12/23/2025
    12/23/25 Clinical Supply Leader Newsletter
  5. 12.16.25 -- EMA's New Framework For Phage-Based Antimicrobial Drugs 12/16/2025
    12/16/25 Clinical Supply Leader Newsletter
  6. 12.09.25 -- On The Potency Assurance Journey, Travelers Need A Road Map 12/9/2025
    12/09/25 Clinical Supply Leader Newsletter
  7. Best of November 2025: Top 5 Insights In Clinical Supply Chain & Logistics 12/3/2025
  8. 12.02.25 -- A Multi-Omics Approach For Characterizing Clinical-Scale iPSC Batches 12/2/2025
    12/02/25 Clinical Supply Leader Newsletter
  9. 11.25.25 -- Global Implications Of Zero Tariffs On Indian Pharma Exports To China 11/25/2025
    11/25/25 Clinical Supply Leader Newsletter
  10. 11.18.25 -- Why Do So Few Cell Therapies Make The Leap From Lab To GMP? 11/18/2025
    11/18/25 Clinical Supply Leader Newsletter